Back to Agenda
Welcoming Remarks and Session 1: Regional and National Regulatory Updates
Session Chair(s)
Sonia Viejobueno, LLM
Associate Director, Regulatory Policy LATAM, Johnson & Johnson Innovative Medicine, Argentina
Regulatory systems play a crucial role in health systems by ensuring that medicines and other health technologies, including vaccines, blood and blood products, medical devices, among others that are released for the population, are properly evaluated and meet international standards of safety, quality, and effectiveness. This session will gather regulators from Latin America and the Caribbean, who will provide a summary of the progress made on their regulatory projects, take stock of their experiences responding to the COVID-19 pandemic, and describe their plans and priorities for 2022 and beyond.
Learning Objective : At the conclusion of this session, participants should be able to:- Recognize the responsibilities or regulators in improving access to safe, efficacious, and quality medical products
- Distinguish main actions and best practices implemented by health authorities in Latin America and the Caribbean
- Identify current and future regulatory projects and priorities from regulators in the region
Speaker(s)
Maria L Luz Pombo
Unit Chief, quality and regulation of medicines and health technologies, Pan American Health Organization (PAHO), United States
Leonardo Sánchez, PHARMD
Comisionado Adjunto, Agencia de Regulación Sanitaria HONDURAS, Honduras
Joy St.John
Executive Director, Caribbean Public Health Agency (CARPHA), Trinidad And Tobago
Ana Gabriela Silva Flor de Olortegui, RPH
Executive Director of the Pharmaceutical Products Department, DIGEMID, Peru
Miriam Jackeline Jackeline Loera Rosales
Commissioner of Evidence and Risk Management, COFEPRIS, Mexico
Have an account?